North America Infectious Disease Diagnostics by Product & Service (Assays, Kits, & Reagents, Instruments, Services & Software) Technology ( Immunodiagnostics, Clinical Microbiology, Biochemical characterization, Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing & Next-Generation Sequencing (NGS), DNA Microarray, Hybridization, Mass Spectroscopy, Other), Disease Type ( Hepatitis, Acquired Immunodeficiency Syndrome (AIDS), Human Immunodeficiency Virus (HIV), Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG), Hospital-Acquired Infections (HAIS), Human Papillomavirus (HPV), Tuberculosis (TB), Influenza, Other), End User ( Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/Research Institutes, Other ) Country (U.S., Canada, Mexico) Market Trends Forecast to 2027
Market Analysis and Insights: North America Infectious Disease Diagnostics Market
North America infectious disease diagnostics market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 10.95 billionn by 2027 growing at a CAGR of 6.97% in the above-mentioned forecast period. This growth in the market is the move from categorized laboratory to decentralized treatment research laboratory.
Growing incidence of infectious diseases, surge in the grants from numerous government and private organizations and rising demand for new diagnostic tests to monitor infectious diseases is the major driver that will impact this market growth in the forecast period to 2027.
Infectious disease diagnosis relates to the screening or evaluation of the involvement of any infectious organisms in the skin. Collections, tools and sensitive substances are often used to perform these tests. Diagnosis of infectious diseases are services which generally available for bacterial infections and sexually transmitted diseases. There are increasing demands in hospitals, clinical laboratories, referral laboratories, government agencies and research institutes for the testing of infectious disease among the population.
Factor that restraint the growth of the market such as the rigorous regulatory approval process for contagious diagnostic instruments, the advancement of molecular techniques and adverse reimbursement scenarios
North America infectious disease diagnostics market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
North America Infectious Disease Diagnostics Market Scope and Market Size
North America Infectious disease diagnostics market is segmented of the basis of product & service, technology, disease type, end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- Based on product & service the infectious disease diagnostics market is segmented into Assays, Kits, & Reagents, Instruments, Services & Software.
- based on technologyInfectious disease diagnostics market, is segmented into immunodiagnostics, clinical microbiology, biochemical characterization, polymerase chain reaction (pcr), isothermal nucleic acid amplification technology (inaat), dna sequencing & next-generation sequencing (ngs), dna microarray, hybridization, mass spectroscopy, other.
- based on disease type Infectious disease diagnostics market, is segmented into hepatitis, acquired immunodeficiency syndrome (aids), human immunodeficiency virus (hiv), chlamydia trachomatis genital infection and gonorrhea (ct/ng), hospital-acquired infections (hais), human papillomavirus (hpv), tuberculosis (tb) influenza, other.
- By the end user the Infectious disease diagnostics market is segmented into hospital/clinical laboratories, reference laboratories, physician offices, academic/research institutes, other.
North America Infectious Disease Diagnostics Market Country Level Analysis
Infectious Disease Diagnostics Market is analysed and market size information is provided by country by of technology, disease type, and end user as referenced above.
The countries covered in the market report are the U.S., Canada, and Mexico.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands impact of sales channels are considered while provided forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Infectious disease diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Infectious disease diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Infectious disease diagnostics market. The data is available for historic period of 2010 to 2018.
Competitive Landscape and North America Infectious Disease Diagnostics Market Share Analysis
North America Infectious disease diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companyies focus related to North America infectious disease diagnostics market.
The major players covered in the North America infectious disease diagnostics market are Abbott, BD, bioMérieux SA, Danaher, F. Hoffmann-La Roche Ltd, Meridian Bioscience Inc., QIAGEN, Accelerate Diagnostics, Inc., Bio-Rad Laboratories, Inc., DiaSorin Molecular LLC., Luminex Corporation., OpGen, Inc., Quidel Corporation., Thermo Fisher Scientific Inc., Thermo Fisher Scientific Inc., Bruker, Eurofins Scientific, Hologic, Inc., Immunexpress Inc., Response Biomedical Corp., Seegene Inc., T2 Biosystems, Inc. among other domestic players. Market share data is available for North America. DBMR analyst understands competitive strengths and provides competitive analysis for each competitor separately.
Customization Available : North America Infectious Disease Diagnostics Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies we can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.